Price as of close on Nov 3, 2026 · Financials updated Oct 10, 2026
Basics
Sector
Healthcare
Industry
Healthcare Plans
Country
United States
Market cap
10.8B USD
Enterprise value
5.7B USD
Full-time employees
19,000
Overall health
Drawback:growing more slowly than most peersgrowing more slowly than peers
Drawback:higher risk than most peers: less short-term liquidity (current ratio 1.68 vs a peer median of 2.59) and more debt relative to equity (0.90× vs a peer median of 0.22×)higher risk: less liquidity (current ratio 1.68 vs peers 2.59) and more debt vs equity (0.90× vs peers 0.22×)
About average: profitability and valuation
Ranks #903 of 1,157 healthcare companies (bottom 23%)
Returning more cash than it generates. Paid out $2.0B vs $1.5B of free cash flow over the 3 fiscal years to 2025.
Molina Healthcare returned $2.0B to shareholders over three years, 135% of the free cash flow it produced. That gap has to be covered by cash reserves or new debt, which can't last indefinitely.
Earnings slid into a loss. Loss per share this year after a profit last year.
Molina Healthcare made a loss per share in its latest year after a profit the year before.
Operating margin at a 6-year low.1.7% in 2025, the weakest of the last 6 years.
Molina Healthcare's operating margin fell to 1.7% in 2025, its lowest in the 6 years of filings we have.
Borrowing rising faster than profit. Since 2022: debt +73%, operating profit −33%.
Molina Healthcare's debt grew 73% since 2022 while operating profit changed −33%.
StockQuotient Score
35/ 100▼ 1 since Oct 27 closeOct 5 36 → Nov 4 35 (-1)
Since last quarter: No major changeValuation also moves with the share price every day.
Why it changed since the Oct 27, 2026 close: Score 50 → 49
Share price +4.2%-1
Each step re-scores the company against its peers as they were on Oct 28, 2026; the parts add up to the change. Price effects on EBITDA yield are approximate.
Sector-normalized EBITDA, earnings, and free cash flow yields.
Earnings yield-0.1%
SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148
EBITDA yield6.5%
SEC filings · 12 months to Jun 2026Reported value50% base weight · Z-score 0.62Sector median: 0.0401 · MAD: 0.0401
Free cash flow yield2.5%
SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingReported value20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
Questions investors ask about Molina Healthcare
Is Molina Healthcare getting weaker?
Its latest SEC filing (Jul 23, 2026) got weaker in some ways: turned to a loss over the last 12 months; operating profit now covers interest only 1.0x. Its overall score is 35/100, down 1 since Oct 28, 2026.
How is Molina Healthcare valued vs its peers?
Priced about in line with its peers. Valuation scores 49/100 against 1,393 healthcare peers.EBITDA yield 6.5% vs a peer median of 4.0% (stronger than 65% of peers).EBITDA yield 6.5% vs peers 4.0% (stronger than 65% of peers).Earnings yield -0.1% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -0.1% vs peers 1.5% (weaker than 100% of peers).
Is Molina Healthcare growing?
More slowly than most of its peers. Growth scores 31/100 against 1,393 healthcare peers.3-year revenue growth 10.9% vs a peer median of 5.8% (stronger than 64% of peers).3-year revenue growth 10.9% vs peers 5.8% (stronger than 64% of peers).Revenue growth 2.6% vs a peer median of 6.1% (weaker than 62% of peers).Revenue growth 2.6% vs peers 6.1% (weaker than 62% of peers).
How profitable is Molina Healthcare?
About as profitable as its peers. Profitability scores 41/100 against 1,393 healthcare peers.Operating margin 0.5% vs a peer median of 7.1% (weaker than 66% of peers).Operating margin 0.5% vs peers 7.1% (weaker than 66% of peers).
How risky is Molina Healthcare?
Higher risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings.Debt / equity 0.90× vs a peer median of 0.22× (weaker than 79% of peers).Debt / equity 0.90× vs peers 0.22× (weaker than 79% of peers). A relative measure, not a bankruptcy probability.
Latest filing: what changed
Quarter ended Jun 30, 2026 · filed Jul 23, 2026 · compared with the quarter ended Mar 31, 2026
Got weaker
Turned to a loss over the last 12 months
Operating profit now covers interest only 1.0x
Previous quarter
Latest quarter
Change
Revenue (12 months)
45.1B USD
44.5B USD
−1.2%
Net income (12 months)
188.0M USD
−7.0M USD
turned negative
Operating margin
1.0%
0.5%
−0.5 pts
Free cash flow (12 months)
251.0M USD
271.0M USD
+8.0%
Debt
3.8B USD
3.8B USD
+0.1%
Cash
5.3B USD
5.0B USD
−6.2%
Shares outstanding
52.1M
52.2M
+0.2%
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Industry valuation context
Sector: Healthcare · 301 companies
Valuations in Healthcare are within their usual range since 2016.
52% of months since 2016 were valued lower than now.
19% of companies are in the most expensive fifth of their own price-to-sales history.
Over 24 months, company values +8% and earnings +24% (medians): earnings grew faster than prices.
Median price-to-sales is +63% vs the whole market, against a usual +119%.
2016Shaded: most expensive fifth of its range2026
Shown for Healthcare: too few Healthcare Plans companies have a long enough history of their own.
Earnings-based measures are left out for now because many companies in Healthcare are losing money.
Describes valuations since 2016; it does not predict prices. US companies worth $1B+, from SEC filings and month-end prices, as of Aug 2026. Today's companies and industry labels are used throughout. Measured on sales and free cash flow yields. How this works
Financials
Fiscal years from SEC annual filings · change vs the prior year
Key ratios
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Change
Operating margin
3.7%
3.7%
4.6%
4.2%
1.7%
▼ 2.5 pts
Net margin
2.4%
2.5%
3.2%
2.9%
1.0%
▼ 1.9 pts
Return on assets (ROA)
5.4%
6.4%
7.3%
7.5%
3.0%
▼ 4.5 pts
Return on equity (ROE)
25.1%
26.7%
25.9%
26.2%
11.6%
▼ 15 pts
Debt to equity
0.83×
0.73×
0.52×
0.65×
0.93×
▲ 42%
Interest coverage
8.50×
10.66×
14.43×
14.47×
4.07×
▼ 72%
MOH price history
Price history is added with the daily price update and will appear after the next one.